Join to access to all OVN content. Join for Free
From MSL to MSL Recruiter: A Career Transition
Sarah Snyder MSL recruiter networking strategies career transitions recruiter-candidate relationships

From MSL to MSL Recruiter: A Career Transition


Share This Article


Summary

In this episode, Sarah Snyder shares her journey from BioSplice to becoming an MSL recruiter at The Carolan Group. She emphasizes the value of networking and building a strong LinkedIn presence, discussing the emotional challenges of career transitions. Sarah highlights the parallels between MSL and recruiter roles, offering insights into fostering effective recruiter-candidate relationships through transparency and engagement. She provides networking strategies while cautioning against burnout. As the episode celebrates its 100th milestone, Sarah offers reflections and advice for MSL job seekers, encouraging them to maintain updated profiles and embrace career transitions.

My guest today is Sarah Snyder, Executive MSL Recruiter with The Carolan Group and we discuss her career transition from Medical Science Liaison to MSL Recruiter

Sarah shares…

👉 How she made the unique career transition
👉 Why it is a good idea for a job seekers to work with a Recruiter
👉 What is the best way for a job seeker to engage a Recruiter
👉 What Job Seekers do to ensure a successful relationship with a Recruiter

Click for Source
Sarah Snyder, MSL recruiter, networking strategies, career transitions, recruiter-candidate relationships

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Article
Promotability: How to Land Your Next Promotion
Partner Avatar Tom Caravela

Promotability: How to Land Your Next Promotion

Podcast
Surround to Succeed: Building a Motivational Network
Partner Avatar MSL Talk: Tom Caravela, Sarah Snyder

Surround to Succeed: Building a Motivational Network

Podcast
Job Leads: The Do's and Don't of Asking for Referrals
Partner Avatar MSL Talk: Tom Caravela, George Lehman

Job Leads: The Do's and Don't of Asking for Referrals

Article
Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis
OVN Avatar Jayson L. Parker, Sebnem S. Kuzulugil, Kirill Pereverzev, Stephen Mac, Gilberto Lopes, Zain Shah, Ashini Weerasinghe, Daniel Rubinger, Adam Falconi, Ayse Bener, Bora Caglayan, Rohan Tangri, Nicholas Mitsakakis

Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis

Article
Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval
OVN Avatar Avi Cherla, MSc; Huseyin Naci, MHS, PhD; Aaron S. Kesselheim, MD, JD, MPH; Bishal Gyawali, MD, PhD; Elias Mossialos, MD, PhD

Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval

Article
Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review
OVN Avatar Vanessa Arciero, BS, Seanthel Delos Santos, Liza Koshy

Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review

Explore OVN